List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Miplyffa (Arimoclomol) Capsules

Neuro

Brand Name: Miplyffa. Generic Name: (Arimoclomol). It is used to treat Niemann-Pick disease type C (NPC).

MIPLYFFA is prescription medicine used in combination with a drug called miglustat to treat neurological symptoms of Niemann-Pick disease type C (NPC) in patients 2 years of age and older.

Brand Name:	Miplyffa
Generic Name:	Arimoclomol
Strength:	•
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Miplyffa (Arimoclomol) Capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Mogamulizumab-kpkc Injection

Lymphoma

mogamulizumab-kpkc injection
for intravenous use Initial U.S. Approval: 2018

Poteligeo (mogamulizumab) is a medication used to treat adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.

Facts about mogamulizumab-kpkc injection

Disease Indications-Lymphoma
Manufacturer-Kyorin Pharmaceuticals Co
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Mogamulizumab-kpkc Injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

naxitamab-gqgk injection

Lung Cancer

naxitamab-gqgk injection
for intravenous use Initial U.S. Approval: 2020

Danyelza (naxitamab-gqgk) is a medication used to treat children aged 1 year or older and adults with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow.

Facts about naxitamab-gqgk injection

DISEASE INDICATIONS-Neuroblastoma
MANUFACTURER-Y-mAbs Therapeutics
USAGE-Intravenous
Dosage Forms and Strengths: Injection: 40 mg/10 mL (4 mg/mL) in a single-dose vial.
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “naxitamab-gqgk injection” based on the information you provide.

necitumumab injection

Lung Cancer

necitumumab injection
for intravenous use Initial U.S. Approval: 2015

Portrazza (necitumumab) is a medication used for the treatment of metastatic squamous non-small cell lung cancer. This medicine has been approved in The US, Canda and Europe. We can get you the US FDA approved stock.

Facts about necitumumab injection

DISEASE INDICATIONS-Lung Cancer
MANUFACTURER-Eli Lilly Nederland B.V.
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “necitumumab injection” based on the information you provide.

Nelarabine Injection

Lymphoma

Nelarabine Injection
for intravenous use Initial U.S. Approval: : 2005

Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. This use is based on the induction of complete responses. Randomized trials demonstrating increased survival or other clinical benefit have not been conducted.

Facts about Nelarabine Injection

Approval Date: 2005
Proprietary Name: On Request
Active Ingredient(s): Nelarabine Injection
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Nelarabine Injection” based on the information you provide.

Neratinib Tablets

Breast Cancer

neratinib tablets,
for oral use Initial U.S. Approval: 2017

Nerlynx (neratinib) is a medication indicated for the adjuvant treatment of adult patients with early-stage HER2 positive overexpressed/amplified breast cancer.

Facts about neratinib tablets

Disease Indications-Breast Cancer
Manufacturer-Puma biotechnology
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA) Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Neratinib Tablets” based on the information you provide.

NERLYNX (neratinib) tablets

Breast Cancer

NERLYNX (neratinib) tablets, for oral use Initial U.S. Approval: 2017

NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.

Brand Name:	NERLYNX
Generic Name:	neratinib
Strength:	• Tablets: 40 mg.
Manufacturer:	Puma Biotechnology, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import IXEMPRA Kit (ixabepilone) for Injection” based on the information you provide.

Nintedanib Capsules

Lung Cancer

nintedanib capsules
for oral use Initial U.S. Approval: 2014

OFEV is a kinase inhibitor indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

Facts about nintedanib capsules

Approval Date: 2014
Proprietary Name: On Request
Active Ingredient(s): nintedanib capsules
Dosage Forms And Strengths: Capsules: 150 mg and 100 mg
Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Current indications: idiopathic pulmonary fibrosis (IPF).
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “nintedanib capsules” based on the information you provide.

NUBEQA (darolutamide) tablets

Prostate

NUBEQA (darolutamide) tablets

Nubeqa is an androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer.
Nubeqa (darolutamide) a prescription medicine used to treat prostate cancer that has not spread to other parts of your body. Nubeqa is given after surgery or other treatments did not work or have stopped working. It is not known if Nubeqa is safe and effective in children or in females.

Brand Name:	NUBEQA
Generic Name:	darolutamide
Strength:	• Tablets: 300 mg
Manufacturer:	Bayer
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import NUBEQA (darolutamide) tablets” based on the information you provide.

Ocrevus (ocrelizumab)

Multiple Sclerosis, Neuro

Ocrevus (ocrelizumab)

OCREVUS is a prescription medicine used to treat: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Primary progressive MS, in adults.

Brand Name:	Ocrevus
Generic Name:	ocrelizumab
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Ocrevus (ocrelizumab)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Ocrevus (ocrelizumab) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

Brand Name: Miplyffa. Generic Name: (Arimoclomol). It is used to treat Niemann-Pick disease type C (NPC).

mogamulizumab-kpkc injection for intravenous use Initial U.S. Approval: 2018

Facts about mogamulizumab-kpkc injection

Access the best support services globally

naxitamab-gqgk injection for intravenous use Initial U.S. Approval: 2020

Facts about naxitamab-gqgk injection

Access the best support services globally

necitumumab injection for intravenous use Initial U.S. Approval: 2015

Facts about necitumumab injection

Access the best support services globally

Nelarabine Injection for intravenous use Initial U.S. Approval: : 2005

Facts about Nelarabine Injection

Access the best support services globally

neratinib tablets, for oral use Initial U.S. Approval: 2017

Facts about neratinib tablets

Access the best support services globally

NERLYNX (neratinib) tablets, for oral use Initial U.S. Approval: 2017

Access the best support services globally

nintedanib capsules for oral use Initial U.S. Approval: 2014

Facts about nintedanib capsules

Access the best support services globally

NUBEQA (darolutamide) tablets

Access the best support services globally

Ocrevus (ocrelizumab)

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

mogamulizumab-kpkc injection
for intravenous use Initial U.S. Approval: 2018

naxitamab-gqgk injection
for intravenous use Initial U.S. Approval: 2020

necitumumab injection
for intravenous use Initial U.S. Approval: 2015

Nelarabine Injection
for intravenous use Initial U.S. Approval: : 2005

neratinib tablets,
for oral use Initial U.S. Approval: 2017

nintedanib capsules
for oral use Initial U.S. Approval: 2014